XML 69 R53.htm IDEA: XBRL DOCUMENT
v3.20.4

Significant Transactions (Details Textual) $ / shares in Units, $ in Thousands |  |  |  |  | 1 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | ---
Jul. 08, 2020 | Jan. 09, 2020 USD ($) $ / shares | May 07, 2019 shares | Mar. 01, 2019 USD ($) | Dec. 29, 2020 USD ($) | Nov. 29, 2020 shares | Feb. 19, 2020 USD ($) | Dec. 20, 2019 | Apr. 29, 2019 shares | Mar. 31, 2019 shares | Dec. 31, 2020 USD ($) shares | Dec. 31, 2019 USD ($) | Jan. 09, 2020 ₪ / shares
Purchase agreement, description |  |  |  |  |  |  |  | The Company entered into a securities purchase agreement (the "2019 Purchase Agreement") with an accredited investor. Pursuant to the 2019 Purchase Agreement, the Company agreed to sell to the investor, and the investor agreed to purchase from the Company, in a private placement, an aggregate of 2,037,037 shares of Common Stock for a purchase price of $0.27 per share, for aggregate gross proceeds under the 2019 Purchase Agreement of $550. The Company also agreed to issue to the investor the December 2019 Warrants, a five-year warrants to purchase an aggregate of 4,074,047 shares of Common Stock. The December 2019 Warrants have an exercise price of $0.27 per share and will be exercisable five days following the public announcement of positive clinical data results for LO2A. |  |  |  |  |
Escrow amount |  |  |  |  |  |  |  |  |  |  | $ 3,700 |  |
Number of ordinary shares | shares |  |  | 336,000 |  |  |  |  |  | 336,000 | 60,000 |  |  |
Amount of ordinary shares |  |  |  | $ 765 |  |  |  |  |  |  |  | $ 765 |
Marketable securities |  |  |  |  |  |  |  |  |  |  | 1,197 |  |
Company recognized a loss |  |  |  |  |  |  |  |  |  |  | 1,197 | (527) |
Investment in marketable securities |  |  |  |  |  |  |  |  |  |  | 13,851 |  |
Restricted deposit |  |  |  |  |  |  |  |  |  |  | 3,700 |  |
Preferred stock description | The Company elected to redeem all of the Series B Preferred Stock. As a result, the Company distributed 68,191,200 Bonus Shares representing an amount of $6,597 to the holders of Series B Preferred Stock representing 80% of the Bonus shares then held by the Company. As a result of such distribution, as of the date of these financial statements, the Company owns the remaining 18,822,533 Bonus Shares, representing approximately 1.61% of the outstanding shares of Bonus. |  |  |  |  |  |  |  |  |  |  |  |
Received cash proceeds |  |  |  |  |  |  |  |  |  |  | $ 821 |  |
Description of bonus agreements |  |  |  |  |  | (i) the Company will waive the requirement that Bonus will effect the Nasdaq Listing and, in relation thereto, conduct the Milestone Closing (as defined in the Bonus Agreements), which means that, at the Closing, $3.7 million will be released from an existing escrow account to Bonus, whereas the 28,413,000 Bonus Shares held in such escrow (the "Nasdaq Milestone Shares") will be released to the Company (20% of the shares) and to the Company's former holders of Series B Preferred Stock (the "Former Series B Holders"); (ii) the Company will waive approximately $120in liquidated damages that accrued as a result of the delay in effecting the Nasdaq Listing; and (iii) Bonus agreed to extend the period for the Company to create, and cause its Israeli subsidiaries to create, certain first priority liens in favor of Bonus to secure the Company's obligations under the Bonus Exchange Agreement, including certain related negative covenants. The Closing was subject to customary conditions, including obtaining the approval of the TASE, and occurred on December 30, 2020. It should be noted that, in accordance with the Securities Purchase Agreement, dated January 9, 2020 (as amended), by and among the Company and the Former Series B Holders, the Company was required to transfer 80% of the Milestone Settlement Shares and 80% of the Nasdaq Milestone Shares to such investors. |  |  |  |  |  |  |
Series B Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase agreement, description |  |  |  |  |  |  |  |  |  |  | The Company agreed to sell to the investors, and the investors agreed to purchase from the Company, in a private placement, an aggregate of 7,500 shares of newly created Series B Non-Voting Redeemable Preferred Stock, par value $0.001 per share, of the Company ("Series B Preferred Stock") for a purchase price of $1.00 per share, for aggregate gross proceeds under the Series B Purchase Agreement of $7,500, which funds were deposited into an escrow account, of which (i) $500 was to be paid to the Bonus Escrow Account and $100 was paid directly to the Company to cover certain of its transactions expenses, in each case, promptly following the execution of the Series B Purchase Agreement, and (ii) the remaining $6,900 was to be released to the Bonus Escrow Account upon the closing of the transactions contemplated by the Series B Purchase Agreement (of which, as described above, $3,200 was to be released upon the earlier of the Milestone Closing or upon written consent of the holders of at least a majority of the Series B Preferred Stock). |  |
Escrow amount |  |  |  |  | $ 3,700 |  | $ 3,700 |  |  |  | $ 3,700 |  |
Fair value |  |  |  |  |  |  | $ 10,707 |  |  |  | 10,707 |  |
Finance expenses |  |  |  |  |  |  |  |  |  |  | 3,207 |  |
Investment of marketable securities percentage |  |  |  |  |  |  | 80.00% |  |  |  |  |  |
Redeem Series B Preferred Stock, description |  |  |  |  |  | (i) the Milestone Settlement Shares, which, as defined in the Addendum, means Bonus Shares equal to the quotient obtained by dividing US$500 expressed in NIS (based on the exchange rate set in the Addendum) by NIS 0.50, and (ii) the HCW Settlement Shares (together with the Milestone Settlement Shares, the “Settlement Shares”), which, as defined in the Addendum, means Bonus Shares equal to the quotient obtained by dividing US$350 expressed in NIS (based on the exchange rate set in the Addendum) by NIS 0.50. |  |  |  |  |  |  |
Bonus Exchange Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase agreement, description |  | The Company agreed to purchase 51,282,000 ordinary shares of Bonus (the "PIPE Shares", and together with the LO2A Shares, the "Bonus Shares"), for an aggregate purchase price of $7,400 in cash, which funds were deposited directly into an escrow account (the "Bonus Escrow Account"), of which (i) $500 was paid to Bonus as an advance promptly following execution of the Bonus Purchase Agreement, (ii) $3,200 was released to Bonus concurrently with the closing of the transactions contemplated by the Bonus Agreements in exchange for 50% of the PIPE Shares and (iii) $3,700 was released to Bonus upon the Milestone Closing (as defined in the Bonus Purchase Agreement), in exchange for the remaining 50% of the PIPE Shares that were issued by Bonus and deposited into the escrow at the closing. The Company's obligation to consummate the Milestone Closing is conditioned upon the satisfaction by Bonus of certain conditions, including the listing of its ordinary shares (or, if an ADR Program is to be implemented by Bonus, the American Depositary Shares representing such ordinary shares) on the Nasdaq Capital Market (or another superior tier of the Nasdaq market) (the "Nasdaq Listing"). |  |  |  |  |  |  |  |  |  |  |
Escrow amount |  |  |  |  |  |  |  |  |  |  | $ 3,700 |  |
Number of ordinary shares | shares |  |  |  |  |  |  |  |  |  |  | 85,239,000 |  |
Additional ordinary shares | shares |  |  |  |  |  |  |  |  |  |  | 28,413,000 |  |
Investment in marketable securities |  |  |  |  |  |  |  |  |  |  | $ 5,871,260 |  |
Loss due to revaluation |  |  |  |  |  |  |  |  |  |  | 597 |  |
Fair value of bonus shares and amount |  |  |  |  |  |  |  |  |  |  | 8,759 |  |
Received cash proceeds |  |  |  |  |  |  |  |  |  |  | $ 5,059 |  |
Bonus Exchange Agreement [Member] | Series B Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase agreement, description |  |  |  |  |  |  |  |  |  |  | Pursuant to the Bonus Agreements (as amended as of June 24, 2020), Bonus agreed to cover nearly 50% of the Company's fees and expenses payable by the Company in cash, Bonus shares and/or a combination thereof to H.C. Wainwright & Co., LLC ("HCW") in connection with the transactions contemplated by the Bonus Agreements and the Series B Purchase Agreement (as defined below). In particular, Bonus agreed to reimburse the Company or pay HCW directly $350 in cash, Bonus shares and/or a combination thereof. |  |
Escrow amount |  | $ 3,700 |  |  |  |  |  |  |  |  |  |  |
Bonus Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase agreement, description |  | Pursuant to the Bonus Agreements, the Company agreed to grant Bonus, in consideration for the issuance of 62,370,000 ordinary shares of Bonus to the Company (the "LO2A Shares"), the right to receive 37% of future LO2A Proceeds (if any), which, as more fully defined in the Bonus Exchange Agreement, include proceeds generated by the Company, Wize Israel and OcuWize, as a result of (i) the sale, license or other disposal of products or other rights underlying the LO2A technology licensed to OcuWize under the License Agreement; and (ii) a Sale Transaction, which, as more fully defined in the Bonus Exchange Agreement, includes the sale of shares or assets of Wize Israel and/or OcuWize. In addition, if the Sale Transaction involves a change of control of the Company, Bonus will be entitled to elect, to either remain with its right to 37% of the LO2A Proceeds or receive a one-time payment equal to 37% of the value attributed to Wize Israel out of the total proceeds payable for the Company in such transaction. |  |  |  |  |  |  |  |  |  |  |
Price per share at the date of agreement | $ / shares |  | $ 0.12 |  |  |  |  |  |  |  |  |  |  |
Price per share at the closing date | $ / shares |  | $ 0.11 |  |  |  |  |  |  |  |  |  |  |
Outstanding share capital percentage |  | 12.00% |  |  |  |  |  |  |  |  |  |  |
Amount of ordinary shares |  | $ 16,400 |  |  |  |  |  |  |  |  |  |  |
Bonus Agreements [Member] | NIS [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share | ₪ / shares |  |  |  |  |  |  |  |  |  |  |  |  | ₪ 0.50
Bonus Agreements [Member] | Series B Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Bonus transaction | shares |  |  |  |  |  | 119,294,300 |  |  |  |  |  |  |
Bonus shares series B Preferred stock. | shares |  |  |  |  |  | 93,576,800 |  |  |  |  |  |  |
Series B Purchase Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase agreement, description |  |  |  |  |  |  |  |  |  |  | Pursuant to the Series B Certificate of Designations, the Company designated 7,500 shares of preferred stock as Series B Preferred Stock. The Series B Preferred Stock were not convertible into shares of Common Stock of the Company and have no voting powers, except as related to certain rights to protect the rights and preferences of the Series B Preferred Stock and with respect to sales or dispositions of the Series B Preferred Stock at a price per share below the Price Restriction. The Series B Preferred Stock entitled its holders to (i) 80% of the proceeds received by the Company through future sales of the Bonus Shares issued to the Company under the Bonus Agreements and (ii) 80% of any cash dividends received by the Company on such Bonus Shares. Under the Series B Certificate of Designations, the Company had the option to redeem the Series B Preferred Stock at any time by distributing to holders of the Series B Preferred Stock (i) 80% of the Bonus Shares then held by the Company and (ii) 80% of all dividends received by the Company but not yet paid to holders of the Series B Preferred Stock (the "Redemption Payment"). The Company was required to redeem the Series B Preferred Stock through payment of the Redemption Payment upon the earlier of (i) 60 days following the Nasdaq Listing of the Bonus Shares, and (ii) December 28, 2020. |  |
Cash of investment |  |  |  |  |  |  |  |  |  |  | $ 7,500 |  |
Settlement Shares [Member] | Series B Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Description of bonus agreements |  |  |  |  |  | (i) the Company will waive the requirement that Bonus will effect the Nasdaq Listing and, in relation thereto, conduct the Milestone Closing, which means that US$3.7 million were released from an existing escrow account to Bonus, whereas the 28,413,000 Bonus Shares held in such escrow (the “Nasdaq Milestone Shares”) were released to the Company and to its former holders of Series B Preferred Stock (the “Former Series B Holders”); (ii) the Company will waive approximately US$120 in liquidated damages that accrued as a result of the delay in effecting the Nasdaq Listing; and (iii) Bonus agreed to extend the period for the Company to create, and cause its Israeli subsidiaries to create, certain first priority liens in favor of Bonus to secure obligations under the Bonus Exchange Agreement, including certain related negative covenants. The closing occurred on December 29, 2020. It should be noted that, in accordance with the obligations of the Company to the Former Series B Holders (see below), the Company has transferred 80% of the Milestone Settlement Shares and 80% of the Nasdaq Milestone Shares to such investors. |  |  |  |  |  |  |

X
- Definition Amount of investment in marketable security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.4) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 + Details
Name: | us-gaap_MarketableSecurities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI). + References No definition available. + Details
Name: | us-gaap_MarketableSecuritiesGainLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Describe the contractual rights of preferred stockholders to receive dividends or returns from the entity's profits, cash flows, or returns on investments. + References No definition available. + Details
Name: | us-gaap_PreferredStockParticipationRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910 + Details
Name: | us-gaap_RestrictedCash
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | wizp_AdditionalOrdinaryShares
Namespace Prefix: | wizp_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Bonus shares series B Preferred stock. + References No definition available. + Details
Name: | wizp_BonusSharesOfSeriesBPreferredStock.
Namespace Prefix: | wizp_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Bonus transaction by shares. + References No definition available. + Details
Name: | wizp_BonusTransaction
Namespace Prefix: | wizp_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | wizp_CashOfInvestment
Namespace Prefix: | wizp_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Description of bonus agreements. + References No definition available. + Details
Name: | wizp_DescriptionOfBonusAgreements
Namespace Prefix: | wizp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | wizp_EscrowAmount
Namespace Prefix: | wizp_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair value of bonus shares and amount. + References No definition available. + Details
Name: | wizp_FairValueOfBonusSharesAndAmount
Namespace Prefix: | wizp_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | wizp_FinanceExpenses
Namespace Prefix: | wizp_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of Investment in marketable securities (Bonus shares) + References No definition available. + Details
Name: | wizp_InvestmentInMarketableSecuritiesBonusShares
Namespace Prefix: | wizp_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | wizp_InvestmentOfMarketableSecuritiesPercentage
Namespace Prefix: | wizp_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of loss due to revaluation. + References No definition available. + Details
Name: | wizp_LossDueToRevaluation
Namespace Prefix: | wizp_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | wizp_OutstandingShareCapitalPercentage
Namespace Prefix: | wizp_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Price per share at the closing date. + References No definition available. + Details
Name: | wizp_PricePerShareAtClosingDate
Namespace Prefix: | wizp_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Price per share at the date of agreement. + References No definition available. + Details
Name: | wizp_PricePerShareAtDateOfAgreement
Namespace Prefix: | wizp_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Received cash proceeds. + References No definition available. + Details
Name: | wizp_ReceivedCashProceeds
Namespace Prefix: | wizp_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Redeem all of the Series B Preferred Stock, description. + References No definition available. + Details
Name: | wizp_RedeemAllOfSeriesBPreferredStockDescription
Namespace Prefix: | wizp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | wizp_RedeemableFairValue
Namespace Prefix: | wizp_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Purchase agreement, description. + References No definition available. + Details
Name: | wizp_SecuritiesPurchaseAgreementDescription
Namespace Prefix: | wizp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | wizp_TypeOfAgreementAxis=wizp_BonusExchangeAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | wizp_TypeOfAgreementAxis=wizp_BonusAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | wizp_TypesOfCurrencyAxis=wizp_IsraeliShekelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | wizp_TypeOfAgreementAxis=wizp_SeriesBPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | wizp_TypeOfAgreementAxis=wizp_SettlementSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |